OBJECTIVE: SMFM and ACOG guidelines recommend comprehensive prenatal diagnosis in pregnancy. Upon detection of structural abnormalities during the anatomic ultrasound, it is recommended that women undergo counseling including the opportunity for additional diagnostic testing including chromosomal microarray analysis (CMA). With the added prognostic value of a significant CMA abnormality, some women may desire pregnancy termination.
However, twenty states have enacted laws prohibiting abortion beyond 20 weeks' gestation; currently 17 are active. We sought to estimate the effect of 20-week abortion bans on health outcomes and costs in the setting of a fetal diagnosis from microarray with an underlying structural anomaly. STUDY DESIGN: A decision-analytic model was built using TreeAge software to evaluate the impact of a 20-week ban on abortion in a theoretical cohort of 10,000 women with abnormal CMA after identification of structural abnormalities on ultrasound. Outcomes included number of abortions, maternal death, neonatal death, intrauterine fetal demise, and a child with moderate or severe chromosomal microdeletions, in addition to cost and quality-adjustedlife-years (QALY). The threshold for cost-effectiveness was set to $100,000 per QALY. Sensitivity analyses were performed broadly. RESULTS: In this hypothetical cohort, a 20-week abortion ban results in an additional 217 stillbirths, 337 neonatal deaths. There would be 1,823 fewer terminations of pregnancy. The presence of a ban results in 48,148 fewer maternal QALYs and costs society over $3.3 billion. Among the 5,958 women who would consider termination, 1,650 would still travel out of state to obtain the abortion. In sensitivity analyses, not having a ban in place remained the cost-effective strategy until abortion cost over 920 times its current cost. CONCLUSION: Policies prohibiting termination of pregnancy after 20 weeks' gestation are associated with significant societal costs and worsened maternal outcomes when considering a population of women with abnormal ultrasound and CMA. With increased utilization and improved resolution of CMA testing, the magnitude of this impact may increase. hypertension, an anomalous fetus, or abnormal cfDNA screening results. Indicators of placental compromise, including hypertensive disease of pregnancy, oligohydramnios, intrauterine growth restriction (IUGR), and abruption were assessed as individual outcomes and as a composite outcome. Low fetal fraction was defined as <25 th percentile. We calculated BMI-adjusted risk ratios (aRR) and 95% confidence intervals (CI). RESULTS: Low fetal fraction was associated with the composite outcome of placental compromise (aRR 1.5; CI 1.1-2.2). Low fetal fraction was also associated with individual outcomes of hypertensive disease of pregnancy (aRR 1.6; CI 1.003-2.6) and preeclampsia with severe features (aRR 3.3; CI 1.2-8.9). Though not significant, the incidence of oligohydramnios, IUGR, and low Apgars (<5 at 1 minute or <7 at 5 minutes) was greater in the low fetal fraction cohort. CONCLUSION: Low fetal fraction of cfDNA among asymptomatic women may serve as a biomarker for subsequent placental dysfunction and hypertensive disease. cfDNA testing may enhance the diagnostic value of traditional serum analogues, such as PAPP-A, in quantifying individual risk.
897 Pregnancy-associated changes in cervical regulatory non-coding RNA
, Miriam J. Haviland 3 , Jonathan L. Hecht OBJECTIVE: Non-coding RNA (ncRNA) are small regulatory molecules, including microRNA (miRNA) and long non-coding RNA (lncRNA), that may serve as biomarkers for adverse pregnancy outcomes. Characterizing ncRNA local expression in response to pregnancy will advance understanding of reproductive physiology. This study aimed to identify pregnancy-associated changes in cervical miRNA and lncRNA, as well as their impact on biologic processes. STUDY DESIGN: This is a matched, nested case-control study of 21 pregnant and 21 non-pregnant women from an ongoing prospective pregnancy cohort. Pregnant women were >18 years of age, had cervical swabs collected at a mean of 15 weeks' gestation, and had term singleton deliveries. Non-pregnant women were 18-45 years of age receiving routine gynecologic care. Participants were matched on age, race, and parity. miRNA were measured with a TaqMan OpenArray PCR platform. Putative mRNA targets were identified via TargetScan and queried using Panther Gene Ontology Classification to identify gene enrichment in biological processes. mRNA and lncRNA were measured with ArrayStar LncRNA Microarray. We adjusted analyses for leukocyte burden and used multivariable linear regression with Bonferroni correction and a 2-fold change cut off to compare miRNA, mRNA, and lncRNA expression. RESULTS: Five miRNA (miR-126, miR-150, miR-21, miR-101, and miR-335) were differentially expressed in cervical samples from pregnant women; all were downregulated. Putative targets of these miRNA are enriched in genes mediating organogenesis, cell adhesion and motility, glucocorticoid signaling, and ncRNA machinery. Five mRNA were differentially expressed; all were upregulated in pregnancy. Two of these transcripts, SRRM4 and
